Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn’s Disease
Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn’s Disease
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Background
Infliximab has been shown to have beneficial effects on bone metabolism in patients with Crohn’s disease (CD) although as yet the exact mechanisms have not been fully elucidated.
Aim
To evaluate the impact of adalimumab therapy on bone metabolism using a combined in vivo and in vitro model.
Methods
Parathyroid hormone, vit...
Alternative Titles
Full title
Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn’s Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1688006271
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1688006271
Other Identifiers
ISSN
0163-2116
E-ISSN
1573-2568
DOI
10.1007/s10620-015-3606-z
